Modeling the potential impact of host population survival on the evolution of M. tuberculosis latency

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Zheng, Nibiao ^a   Whalen, Christopher C ^a   Handel, Andreas ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; EVOLUTION; HOST; LATENT PERIOD; MATHEMATICAL MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; SIMULATION; STOCHASTIC MODEL; SURVIVAL; TUBERCULOSIS; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; LATENT TUBERCULOSIS; MICROBIOLOGY; MORTALITY; PHYSIOLOGY; STATISTICS;

BIOLOGICAL EVOLUTION; HUMANS; LATENT TUBERCULOSIS; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; STOCHASTIC PROCESSES;

EID: 84923213747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105721     Document Type: Article

References (84)

1. Brites D, Gagneux S (2012) Old and new selective pressures on mycobacterium tuberculosis. Infect Genet Evol 12: 678-685.
2. Gomez JE, McKinney JD (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84: 29-44. (Pubitemid 38082931)
3. Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
4. Kirschner DE, Young D, Flynn JL (2010) Tuberculosis: global approaches to a global disease. Curr Opin Biotechnol 21: 524-531.
5. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C (2003) Tuberculosis. Lancet 362: 887-899. (Pubitemid 37130100)
6. Chan J, Flynn J (2004) The immunological aspects of latency in tuberculosis. Clin Immunol 110: 2-12. (Pubitemid 38177416)
7. Young D, Stark J, Kirschner D (2008) Systems biology of persistent infection: Tuberculosis as a case study. Nat Rev Microbiol 6: 520-528. (Pubitemid 351850976)
8. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393-422.
9. Bauer AL, Hogue IB, Marino S, Kirschner DE (2008) The effects of hiv-1 infection on latent tuberculosis. Mathematical Modelling of Natural Phenomena 3: 229-266.
10. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the hiv epidemic. Arch Intern Med 163: 1009-21. (Pubitemid 36548927)
11. Whalen CC, Zalwango S, Chiunda A, Malone L, Eisenach K, et al. (2011) Secondary attack rate of tuberculosis in urban households in kampala, uganda. PLoS One 6: e16137.
12. Gagneux S (2012) Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc Lond B Biol Sci 367: 850-859.
13. Comas I, Gagneux S (2011) A role for systems epidemiology in tuberculosis research. Trends Microbiol 19: 492-500.
14. Gagneux S, Small PM (2007) Global phylogeography of mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7: 328-337. (Pubitemid 46590063)
15. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NTN, et al. (2008) The influence of host and bacterial genotype on the development of disseminated disease with mycobacterium tuberculosis. PLoS Pathog 4: e1000034.
16. Mller M, de Wit E, Hoal EG (2010) Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 58: 3-26.
17. Coscolla M, Gagneux S (2010) Does m. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech 7: e43-e59.
18. Holmes EC (2009) The Evolutionary Genetics of Emerging Viruses. ANNUAL REVIEW OF ECOLOGY EVOLUTION AND SYSTEMATICS 40: 353-372.
19. Kawecki TJ, Lenski RE, Ebert D, Hollis B, Olivieri I, et al. (2012) Experimental evolution. Trends Ecol Evol 27: 547-560.
20. Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nature Medicine 10: S122-S129. (Pubitemid 40018235)
21. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, et al. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375: 1830-1843.
22. Flynn JL, Chan J (2005) What's good for the host is good for the bug. Trends Microbiol 13: 98-102. (Pubitemid 40311891)
23. Blaser MJ, Kirschner D (2007) The equilibria that allow bacterial persistence in human hosts. Nature 449: 843-849. (Pubitemid 47598613)
24. Heffernan JM, Smith RJ, Wahl LM (2005) Perspectives on the basic reproductive ratio. J R Soc Interface 2: 281-293.
25. Keeling M, Rohani P (2007) Modeling Infectious Diseases in Humans and Animals. Princeton University Press.
26. Rankin DJ, Bargum K, Kokko H (2007) The tragedy of the commons in evolutionary biology. Trends Ecol Evol 22: 643-651. (Pubitemid 350180145)
27. Lion S, Baalen Mv (2008) Self-structuring in spatial evolutionary ecology. Ecol Lett 11: 277-295.
28. Messinger SM, Ostling A (2009) The consequences of spatial structure for the evolution of pathogen transmission rate and virulence. Am Nat 174: 441-454.
29. Parvinen K, Dieckmann U (2013) Self-extinction through optimizing selection. J Theor Biol 333: 1-9.
30. Lenski RE, May RM (1994) The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses. J Theor Biol 169: 253-265.
31. Keeling M (2000) Evolutionary trade-offs at two time-scales: competition versus persistence. Proc Biol Sci 267: 385-391.
32. Day T, Gandon S (2007) Applying population-genetic models in theoretical evolutionary epidemiology. Ecol Lett 10: 876-888. (Pubitemid 47383382)
33. Bahi-Jaber N, Fouchet D, Pontier D (2008) Stochastic extinction and the selection of the transmission mode in microparasites. J R Soc Interface 5: 1031-1039. (Pubitemid 352020056)
34. King AA, Shrestha S, Harvill ET, Bjrnstad ON (2009) Evolution of acute infections and the invasion-persistence trade-off. Am Nat 173: 446-455.
35. Donoghue HD, Spigelman M, Greenblatt CL, Lev-Maor G, Bar-Gal GK, et al. (2004) Tuberculosis: from prehistory to robert koch, as revealed by ancient dna. Lancet Infect Dis 4: 584-592. (Pubitemid 39141800)
36. Wilbur AK, Farnbach AW, Knudson KJ, Buikstra JE (2008) Diet, tuberculosis, and the paleopathological record. Curr Anthropol 49: 963-77; discussion 977-91.
37. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, et al. (2008) High functional diversity in mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 6: e311.
38. Smith NH, Hewinson RG, Kremer K, Brosch R, Gordon SV (2009) Myths and misconceptions: the origin and evolution of mycobacterium tuberculosis. Nat Rev Microbiol 7: 537-544.
39. Haraguchi Y, Sasaki A (2000) The evolution of parasite virulence and transmission rate in a spatially structured population. J Theor Biol 203: 85-96. (Pubitemid 30662941)
40. Kerr B, Neuhauser C, Bohannan BJM, Dean AM (2006) Local migration promotes competitive restraint in a host-pathogen 'tragedy of the commons'. Nature 442: 75-78. (Pubitemid 44064211)
41. Ernst JD, Trevejo-Nuez G, Banaiee N (2007) Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. J Clin Invest 117: 1738-1745. (Pubitemid 47036304)
42. Castillo-Chavez C, Song B (2004) Dynamical models of tuberculosis and their applications. Math Biosci Eng 1: 361-404.
43. Basu S, Galvani AP (2009) The evolution of tuberculosis virulence. Bull Math Biol 71: 1073-1088.
44. Begon M, Bennett M, Bowers RG, French NP, Hazel SM, et al. (2002) A clarification of transmission terms in host-microparasite models: numbers, densities and areas. Epidemiol Infect 129: 147-153.
45. Sutherland I, Svandova E, Radhakrishna S (1982) The development of clinical tuberculosis following infection with tubercle bacilli. 1. a theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the netherlands. Tubercle 63: 255-68.
46. Vynnycky E, Fine PE (1997) The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 119: 183-201. (Pubitemid 27474799)
47. Chiang CY, Riley LW (2005) Exogenous reinfection in tuberculosis. Lancet Infect Dis 5: 629-636.
48. Cohen T, Colijn C, Finklea B, Murray M (2007) Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. Journal of The Royal Society Interface 4: 523-531. (Pubitemid 46846680)
49. Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, et al. (2012) Risk of progression to active tuberculosis following reinfection with mycobacterium tuberculosis. Clin Infect Dis 54: 784-791.
50. Bacaer N, Ouifki R, Pretorius C, Wood R, Williams B (2008) Modeling the joint epidemics of tb and hiv in a south african township. J Math Biol 57: 557-93.
51. Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C (2005) The impact of hiv/aids on the control of tuberculosis in india. Proc Natl Acad Sci U S A 102: 9619-24. (Pubitemid 40981730)
52. Guzzetta G, Ajelli M, Yang Z, Merler S, Furlanello C, et al. (2011) Modeling socio-demography to capture tuberculosis transmission dynamics in a low burden setting. J Theor Biol 289: 197-205.
53. R Development Core Team (2013). R: A language and environment for statistical computing. http://www.r-project.org/. ISBN 3-900051-07-0.
54. Bonhoeffer S, Lenski RE, Ebert D (1996) The curse of the pharaoh: the evolution of virulence in pathogens with long living propagules. Proc Biol Sci 263: 715-721.
55. Walther BA, Ewald PW (2004) Pathogen survival in the external environment and the evolution of virulence. Biol Rev Camb Philos Soc 79: 849-869. (Pubitemid 39577125)
56. Handel A, Bennett MR (2008) Surviving the bottleneck: transmission mutants and the evolution of microbial populations. Genetics 180: 2193-2200.
57. Caraco T, Wang IN (2008) Free-living pathogens: life-history constraints and strain competition. J Theor Biol 250: 569-579.
58. Handel A, Brown J, Stallknecht D, Rohani P (2013) A multi-scale analysis of influenza a virus fitness trade-offs due to temperature-dependent virus persistence. PLoS computational biology 9: e1002989.
59. Allen LJ, Burgin AM (2000) Comparison of deterministic and stochastic sis and sir models in discrete time. Math Biosci 163: 1-33. (Pubitemid 30054048)
60. Allen LJS (2003) An introduction to stochastic processes with applications in biology. New Jersey: Pearson Education Inc.
61. Nasell I (2002) Stochastic models of some epidemic infections. Mathematical Biosciences 179: 1-19.
62. Vynnycky E, Fine PE (2000) Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 152: 247-263. (Pubitemid 30640248)
63. Dye C, Glaziou P, Floyd K, Raviglione M (2013) Prospects for tuberculosis elimination. Annu Rev Public Health 34: 271-286.
64. Sanchez MA, Blower SM (1997) Uncertainty and sensitivity analysis of the basic reproductive rate. tuberculosis as an example. Am J Epidemiol 145: 1127-1137. (Pubitemid 27272943)
65. Marino S, Hogue IB, Ray CJ, Kirschner DE (2008) A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 254: 178-196.
66. Hoare A, Regan DG, Wilson DP (2008) Sampling and sensitivity analyses tools (sasat) for computational modelling. Theor Biol Med Model 5: 4.
67. Handel A, Longini Jr IM, Antia R (2009) Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. Epidemics 1: 185-195.
68. Handel A, Longini IM, Antia R (2009) Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details. Journal of theoretical biology 256: 117-125.
69. Johnson P (2013) adaptivetau: Tau-leaping stochastic simulation. URL http://CRAN.R-project.org/package= adaptivetau. R package version 1.1.
70. Cao Y, Gillespie DT, Petzold LR (2007) Adaptive explicit-implicit tau-leaping method with automatic tau selection. J Chem Phys 126: 224101.
71. Keeling MJ, Grenfell BT (1997) Disease extinction and community size: modeling the persistence of measles. Science 275: 65-67. (Pubitemid 27020307)
72. Keeling MJ, Grenfell BT (2002) Understanding the persistence of measles: reconciling theory, simulation and observation. Proc Biol Sci 269: 335-343. (Pubitemid 34214550)
73. Blower SM, McLean AR, Porco TC, Small PM, Hopewell PC, et al. (1995) The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med 1: 815-21.
74. Nicol MP, Wilkinson RJ (2008) The clinical consequences of strain diversity in mycobacterium tuberculosis. Trans R Soc Trop Med Hyg 102: 955-965.
75. de Jong BC, Hill PC, Aiken A, Awine T, Antonio M, et al. (2008) Progression to active tuberculosis, but not transmission, varies by mycobacterium tuberculosis lineage in the gambia. J Infect Dis 198: 1037-1043.
76. Hurtado AM, Hill KR, Rosenblatt W, Bender J, Scharmen T (2003) Longitudinal study of tuberculosis outcomes among immunologically naive ach natives of paraguay. Am J Phys Anthropol 121: 134-150. (Pubitemid 36622389)
77. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, et al. (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545-550. (Pubitemid 19070537)
78. Antonucci G, Girardi E, Raviglione MC, Ippolito G (1995) Risk factors for tuberculosis in hiv-infected persons. a prospective cohort study. the gruppo italiano di studio tubercolosi e aids (gista). JAMA 274: 143-148.
79. Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, et al. (1997) A trial of three regimens to prevent tuberculosis in ugandan adults infected with the human immunodeficiency virus. uganda-case western reserve university research collaboration. N Engl J Med 337: 801-808. (Pubitemid 27391629)
80. Ottenhoff THM, Kaufmann SHE (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8: e1002607.
81. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ (2011) Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in hiv negative patients: a systematic review. PLoS One 6: e17601.
82. Trunz BB, Fine P, Dye C (2006) Effect of bcg vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173-1180.
83. van Leth F, van der Werf MJ, Borgdorff MW (2008) Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the styblo rule. Bull World Health Organ 86: 20-26.
84. Dowdy DW, Davis JL, den Boon S, Walter ND, Katamba A, et al. (2013) Population-level impact of same-day microscopy and xpert mtb/rif for tuberculosis diagnosis in africa. PLoS One 8: e70485.